$CME

CME Group Q3 2026 slides: record revenue, 13% earnings growth

CME Group reported record Q3 2026 revenue of $1.74B, up 13% YoY, with EPS of $3.02, beating estimates. Shares fell 1% premarket. Growth driven by global market volatility and product innovation. International ADV up 22% YoY. Management expects record full-year performance.

Original reporting
Published Oct 21, 2026, 1:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 3:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CME
Bearish
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CMEBearishHigh
01

Why it matters

The results confirm CME's dominant market position but suggest limited short‑term upside as expectations were largely met.

02

Market read

Earnings beat with modest share dip; strong volume metrics may influence broader market sentiment on exchange stocks.

03

What to watch

Upcoming fee changes and cloud migration investments may drive longer‑term earnings growth beyond the quarter.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

CME Group's Q3 2026 earnings release highlighted record revenue, double‑digit growth across all segments, and continued international expansion.

Company-level read

Ticker impact

$CMEBearishHigh confidence
Context

CME Group reported Q3 2026 earnings with record revenue of $1.74B and EPS $3.02, beating estimates.

Expected impact

likely slight pressure as market priced in strong results

Evidence & confidence

Despite beating forecasts, the 1% pre‑market decline suggests investors had expectations already priced in, limiting upside.

Market effects

Strong volume growth across all asset classes may boost other exchange operators and related technology providers.

International trading volume surge highlights continued demand in APAC and EMEA, supporting regional brokers.

Record ADV and open interest reinforce CME's role as a key liquidity provider in global derivatives markets.

Counterpoint

The earnings beat could be a buying opportunity if the market overreacted to the modest pre‑market dip.

Key entities

  • CME Group Inc.

    Global derivatives exchange operator.

Related articles

$CMEMed

CME Group Q3 Earnings Call Highlights

CME Group reported average daily margin savings of over $100 billion in Q3, driven by equities and fixed income. Equities savings totaled $47 billion, while fixed income saw record daily savings. International volume rose 22% to 9 million contracts. New products include Single Stock futures and expanded 24/7 trading. CME expects to launch CME Securities Clearing in December and is testing cloud migration. Pricing changes are expected to increase fees by 0.5% to 1%.

$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.